Global Respiratory Pathogen Nucleic Acid Detection Kit Market Research Report 2023

Publication ID:

PB502234041

Publication Date:

February 28, 2023

Pages:

105

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Highlights
The global Respiratory Pathogen Nucleic Acid Detection Kit market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Respiratory Pathogen Nucleic Acid Detection Kit is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Respiratory Pathogen Nucleic Acid Detection Kit is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Respiratory Pathogen Nucleic Acid Detection Kit include CapitalBio, EasyScreen Limited, Tsinghua Holdings Co Ltd., Thermal Fisher, Weifang Kanghua Biotech Co.,Ltd, CapitalBio, BGI, Eiken Chemical and Deaou Biotechnology, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Respiratory Pathogen Nucleic Acid Detection Kit, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Pathogen Nucleic Acid Detection Kit.
The Respiratory Pathogen Nucleic Acid Detection Kit market size, estimations, and forecasts are provided in terms of sales volume () and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Respiratory Pathogen Nucleic Acid Detection Kit market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Respiratory Pathogen Nucleic Acid Detection Kit manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
CapitalBio
EasyScreen Limited
Tsinghua Holdings Co Ltd.
Thermal Fisher
Weifang Kanghua Biotech Co.,Ltd
CapitalBio
BGI
Eiken Chemical
Deaou Biotechnology
Singuway
New England Biolabs
Lucigen Corporation
Merck
Mast Group
OptiGene
Luminex Corporation
Segment by Type
by Target
DNA
RNA
DNA/RNA
by Pathogene
Chlamydia Trachomatis
Ureaplasma Urealyticum
Neisseria Gonorrhoeae
Mycobacterium Tuberculosis
Mycoplasma Pneumoniae
Others
by Technology
PCR
LAMP
Others
Segment by Application
Diagnostic Use
Research Use
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Respiratory Pathogen Nucleic Acid Detection Kit manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Respiratory Pathogen Nucleic Acid Detection Kit in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Respiratory Pathogen Nucleic Acid Detection Kit Market Overview
1.1 Product Overview and Scope of Respiratory Pathogen Nucleic Acid Detection Kit
1.2 Respiratory Pathogen Nucleic Acid Detection Kit Segment by Target
1.2.1 Global Respiratory Pathogen Nucleic Acid Detection Kit Market Value Comparison by Target (2023-2029)
1.2.2 DNA
1.2.3 RNA
1.2.4 DNA/RNA
1.3 Respiratory Pathogen Nucleic Acid Detection Kit Segment by Application
1.3.1 Global Respiratory Pathogen Nucleic Acid Detection Kit Market Value by Application: (2023-2029)
1.3.2 Diagnostic Use
1.3.3 Research Use
1.4 Global Respiratory Pathogen Nucleic Acid Detection Kit Market Size Estimates and Forecasts
1.4.1 Global Respiratory Pathogen Nucleic Acid Detection Kit Revenue 2018-2029
1.4.2 Global Respiratory Pathogen Nucleic Acid Detection Kit Sales 2018-2029
1.4.3 Global Respiratory Pathogen Nucleic Acid Detection Kit Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Respiratory Pathogen Nucleic Acid Detection Kit Market Competition by Manufacturers
2.1 Global Respiratory Pathogen Nucleic Acid Detection Kit Sales Market Share by Manufacturers (2018-2023)
2.2 Global Respiratory Pathogen Nucleic Acid Detection Kit Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Respiratory Pathogen Nucleic Acid Detection Kit Average Price by Manufacturers (2018-2023)
2.4 Global Respiratory Pathogen Nucleic Acid Detection Kit Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Respiratory Pathogen Nucleic Acid Detection Kit, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Respiratory Pathogen Nucleic Acid Detection Kit, Product Type & Application
2.7 Respiratory Pathogen Nucleic Acid Detection Kit Market Competitive Situation and Trends
2.7.1 Respiratory Pathogen Nucleic Acid Detection Kit Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Respiratory Pathogen Nucleic Acid Detection Kit Players Market Share by Revenue
2.7.3 Global Respiratory Pathogen Nucleic Acid Detection Kit Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Respiratory Pathogen Nucleic Acid Detection Kit Retrospective Market Scenario by Region
3.1 Global Respiratory Pathogen Nucleic Acid Detection Kit Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Respiratory Pathogen Nucleic Acid Detection Kit Global Respiratory Pathogen Nucleic Acid Detection Kit Sales by Region: 2018-2029
3.2.1 Global Respiratory Pathogen Nucleic Acid Detection Kit Sales by Region: 2018-2023
3.2.2 Global Respiratory Pathogen Nucleic Acid Detection Kit Sales by Region: 2024-2029
3.3 Global Respiratory Pathogen Nucleic Acid Detection Kit Global Respiratory Pathogen Nucleic Acid Detection Kit Revenue by Region: 2018-2029
3.3.1 Global Respiratory Pathogen Nucleic Acid Detection Kit Revenue by Region: 2018-2023
3.3.2 Global Respiratory Pathogen Nucleic Acid Detection Kit Revenue by Region: 2024-2029
3.4 North America Respiratory Pathogen Nucleic Acid Detection Kit Market Facts & Figures by Country
3.4.1 North America Respiratory Pathogen Nucleic Acid Detection Kit Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Respiratory Pathogen Nucleic Acid Detection Kit Sales by Country (2018-2029)
3.4.3 North America Respiratory Pathogen Nucleic Acid Detection Kit Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Respiratory Pathogen Nucleic Acid Detection Kit Market Facts & Figures by Country
3.5.1 Europe Respiratory Pathogen Nucleic Acid Detection Kit Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Respiratory Pathogen Nucleic Acid Detection Kit Sales by Country (2018-2029)
3.5.3 Europe Respiratory Pathogen Nucleic Acid Detection Kit Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Respiratory Pathogen Nucleic Acid Detection Kit Market Facts & Figures by Country
3.6.1 Asia Pacific Respiratory Pathogen Nucleic Acid Detection Kit Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Respiratory Pathogen Nucleic Acid Detection Kit Sales by Country (2018-2029)
3.6.3 Asia Pacific Respiratory Pathogen Nucleic Acid Detection Kit Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Respiratory Pathogen Nucleic Acid Detection Kit Market Facts & Figures by Country
3.7.1 Latin America Respiratory Pathogen Nucleic Acid Detection Kit Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Respiratory Pathogen Nucleic Acid Detection Kit Sales by Country (2018-2029)
3.7.3 Latin America Respiratory Pathogen Nucleic Acid Detection Kit Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Respiratory Pathogen Nucleic Acid Detection Kit Market Facts & Figures by Country
3.8.1 Middle East and Africa Respiratory Pathogen Nucleic Acid Detection Kit Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Respiratory Pathogen Nucleic Acid Detection Kit Sales by Country (2018-2029)
3.8.3 Middle East and Africa Respiratory Pathogen Nucleic Acid Detection Kit Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Respiratory Pathogen Nucleic Acid Detection Kit Sales by Type (2018-2029)
4.1.1 Global Respiratory Pathogen Nucleic Acid Detection Kit Sales by Type (2018-2023)
4.1.2 Global Respiratory Pathogen Nucleic Acid Detection Kit Sales by Type (2024-2029)
4.1.3 Global Respiratory Pathogen Nucleic Acid Detection Kit Sales Market Share by Type (2018-2029)
4.2 Global Respiratory Pathogen Nucleic Acid Detection Kit Revenue by Type (2018-2029)
4.2.1 Global Respiratory Pathogen Nucleic Acid Detection Kit Revenue by Type (2018-2023)
4.2.2 Global Respiratory Pathogen Nucleic Acid Detection Kit Revenue by Type (2024-2029)
4.2.3 Global Respiratory Pathogen Nucleic Acid Detection Kit Revenue Market Share by Type (2018-2029)
4.3 Global Respiratory Pathogen Nucleic Acid Detection Kit Price by Type (2018-2029)
5 Segment by Application
5.1 Global Respiratory Pathogen Nucleic Acid Detection Kit Sales by Application (2018-2029)
5.1.1 Global Respiratory Pathogen Nucleic Acid Detection Kit Sales by Application (2018-2023)
5.1.2 Global Respiratory Pathogen Nucleic Acid Detection Kit Sales by Application (2024-2029)
5.1.3 Global Respiratory Pathogen Nucleic Acid Detection Kit Sales Market Share by Application (2018-2029)
5.2 Global Respiratory Pathogen Nucleic Acid Detection Kit Revenue by Application (2018-2029)
5.2.1 Global Respiratory Pathogen Nucleic Acid Detection Kit Revenue by Application (2018-2023)
5.2.2 Global Respiratory Pathogen Nucleic Acid Detection Kit Revenue by Application (2024-2029)
5.2.3 Global Respiratory Pathogen Nucleic Acid Detection Kit Revenue Market Share by Application (2018-2029)
5.3 Global Respiratory Pathogen Nucleic Acid Detection Kit Price by Application (2018-2029)
6 Key Companies Profiled
6.1 CapitalBio
6.1.1 CapitalBio Corporation Information
6.1.2 CapitalBio Description and Business Overview
6.1.3 CapitalBio Respiratory Pathogen Nucleic Acid Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.1.4 CapitalBio Respiratory Pathogen Nucleic Acid Detection Kit Product Portfolio
6.1.5 CapitalBio Recent Developments/Updates
6.2 EasyScreen Limited
6.2.1 EasyScreen Limited Corporation Information
6.2.2 EasyScreen Limited Description and Business Overview
6.2.3 EasyScreen Limited Respiratory Pathogen Nucleic Acid Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.2.4 EasyScreen Limited Respiratory Pathogen Nucleic Acid Detection Kit Product Portfolio
6.2.5 EasyScreen Limited Recent Developments/Updates
6.3 Tsinghua Holdings Co Ltd.
6.3.1 Tsinghua Holdings Co Ltd. Corporation Information
6.3.2 Tsinghua Holdings Co Ltd. Description and Business Overview
6.3.3 Tsinghua Holdings Co Ltd. Respiratory Pathogen Nucleic Acid Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Tsinghua Holdings Co Ltd. Respiratory Pathogen Nucleic Acid Detection Kit Product Portfolio
6.3.5 Tsinghua Holdings Co Ltd. Recent Developments/Updates
6.4 Thermal Fisher
6.4.1 Thermal Fisher Corporation Information
6.4.2 Thermal Fisher Description and Business Overview
6.4.3 Thermal Fisher Respiratory Pathogen Nucleic Acid Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Thermal Fisher Respiratory Pathogen Nucleic Acid Detection Kit Product Portfolio
6.4.5 Thermal Fisher Recent Developments/Updates
6.5 Weifang Kanghua Biotech Co.,Ltd
6.5.1 Weifang Kanghua Biotech Co.,Ltd Corporation Information
6.5.2 Weifang Kanghua Biotech Co.,Ltd Description and Business Overview
6.5.3 Weifang Kanghua Biotech Co.,Ltd Respiratory Pathogen Nucleic Acid Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Weifang Kanghua Biotech Co.,Ltd Respiratory Pathogen Nucleic Acid Detection Kit Product Portfolio
6.5.5 Weifang Kanghua Biotech Co.,Ltd Recent Developments/Updates
6.6 CapitalBio
6.6.1 CapitalBio Corporation Information
6.6.2 CapitalBio Description and Business Overview
6.6.3 CapitalBio Respiratory Pathogen Nucleic Acid Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.6.4 CapitalBio Respiratory Pathogen Nucleic Acid Detection Kit Product Portfolio
6.6.5 CapitalBio Recent Developments/Updates
6.7 BGI
6.6.1 BGI Corporation Information
6.6.2 BGI Description and Business Overview
6.6.3 BGI Respiratory Pathogen Nucleic Acid Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.4.4 BGI Respiratory Pathogen Nucleic Acid Detection Kit Product Portfolio
6.7.5 BGI Recent Developments/Updates
6.8 Eiken Chemical
6.8.1 Eiken Chemical Corporation Information
6.8.2 Eiken Chemical Description and Business Overview
6.8.3 Eiken Chemical Respiratory Pathogen Nucleic Acid Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Eiken Chemical Respiratory Pathogen Nucleic Acid Detection Kit Product Portfolio
6.8.5 Eiken Chemical Recent Developments/Updates
6.9 Deaou Biotechnology
6.9.1 Deaou Biotechnology Corporation Information
6.9.2 Deaou Biotechnology Description and Business Overview
6.9.3 Deaou Biotechnology Respiratory Pathogen Nucleic Acid Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Deaou Biotechnology Respiratory Pathogen Nucleic Acid Detection Kit Product Portfolio
6.9.5 Deaou Biotechnology Recent Developments/Updates
6.10 Singuway
6.10.1 Singuway Corporation Information
6.10.2 Singuway Description and Business Overview
6.10.3 Singuway Respiratory Pathogen Nucleic Acid Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Singuway Respiratory Pathogen Nucleic Acid Detection Kit Product Portfolio
6.10.5 Singuway Recent Developments/Updates
6.11 New England Biolabs
6.11.1 New England Biolabs Corporation Information
6.11.2 New England Biolabs Respiratory Pathogen Nucleic Acid Detection Kit Description and Business Overview
6.11.3 New England Biolabs Respiratory Pathogen Nucleic Acid Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.11.4 New England Biolabs Respiratory Pathogen Nucleic Acid Detection Kit Product Portfolio
6.11.5 New England Biolabs Recent Developments/Updates
6.12 Lucigen Corporation
6.12.1 Lucigen Corporation Corporation Information
6.12.2 Lucigen Corporation Respiratory Pathogen Nucleic Acid Detection Kit Description and Business Overview
6.12.3 Lucigen Corporation Respiratory Pathogen Nucleic Acid Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Lucigen Corporation Respiratory Pathogen Nucleic Acid Detection Kit Product Portfolio
6.12.5 Lucigen Corporation Recent Developments/Updates
6.13 Merck
6.13.1 Merck Corporation Information
6.13.2 Merck Respiratory Pathogen Nucleic Acid Detection Kit Description and Business Overview
6.13.3 Merck Respiratory Pathogen Nucleic Acid Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Merck Respiratory Pathogen Nucleic Acid Detection Kit Product Portfolio
6.13.5 Merck Recent Developments/Updates
6.14 Mast Group
6.14.1 Mast Group Corporation Information
6.14.2 Mast Group Respiratory Pathogen Nucleic Acid Detection Kit Description and Business Overview
6.14.3 Mast Group Respiratory Pathogen Nucleic Acid Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Mast Group Respiratory Pathogen Nucleic Acid Detection Kit Product Portfolio
6.14.5 Mast Group Recent Developments/Updates
6.15 OptiGene
6.15.1 OptiGene Corporation Information
6.15.2 OptiGene Respiratory Pathogen Nucleic Acid Detection Kit Description and Business Overview
6.15.3 OptiGene Respiratory Pathogen Nucleic Acid Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.15.4 OptiGene Respiratory Pathogen Nucleic Acid Detection Kit Product Portfolio
6.15.5 OptiGene Recent Developments/Updates
6.16 Luminex Corporation
6.16.1 Luminex Corporation Corporation Information
6.16.2 Luminex Corporation Respiratory Pathogen Nucleic Acid Detection Kit Description and Business Overview
6.16.3 Luminex Corporation Respiratory Pathogen Nucleic Acid Detection Kit Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Luminex Corporation Respiratory Pathogen Nucleic Acid Detection Kit Product Portfolio
6.16.5 Luminex Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Respiratory Pathogen Nucleic Acid Detection Kit Industry Chain Analysis
7.2 Respiratory Pathogen Nucleic Acid Detection Kit Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Respiratory Pathogen Nucleic Acid Detection Kit Production Mode & Process
7.4 Respiratory Pathogen Nucleic Acid Detection Kit Sales and Marketing
7.4.1 Respiratory Pathogen Nucleic Acid Detection Kit Sales Channels
7.4.2 Respiratory Pathogen Nucleic Acid Detection Kit Distributors
7.5 Respiratory Pathogen Nucleic Acid Detection Kit Customers
8 Respiratory Pathogen Nucleic Acid Detection Kit Market Dynamics
8.1 Respiratory Pathogen Nucleic Acid Detection Kit Industry Trends
8.2 Respiratory Pathogen Nucleic Acid Detection Kit Market Drivers
8.3 Respiratory Pathogen Nucleic Acid Detection Kit Market Challenges
8.4 Respiratory Pathogen Nucleic Acid Detection Kit Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

CapitalBio
EasyScreen Limited
Tsinghua Holdings Co Ltd.
Thermal Fisher
Weifang Kanghua Biotech Co.,Ltd
CapitalBio
BGI
Eiken Chemical
Deaou Biotechnology
Singuway
New England Biolabs
Lucigen Corporation
Merck
Mast Group
OptiGene
Luminex Corporation

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂